Recent IDYA News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 10:04:53 AM
- IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 05/07/2024 10:00:00 AM
- IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event • PR Newswire (US) • 05/01/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/26/2024 10:00:00 AM
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study • PR Newswire (US) • 04/24/2024 02:05:00 PM
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer • PR Newswire (US) • 04/22/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/05/2024 10:00:00 AM
- IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event • PR Newswire (US) • 04/01/2024 10:00:00 AM
- IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer • PR Newswire (US) • 03/12/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:27:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:26:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:24:52 PM
- IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events • PR Newswire (US) • 03/04/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:31:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:07:03 AM
- IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update • PR Newswire (US) • 02/20/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:44:22 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:31:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:59:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2024 10:56:04 PM
- IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events • PR Newswire (US) • 02/01/2024 11:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/26/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:12:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 11:03:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 10:18:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM